ClinicalTrials.Veeva

Menu
C

Cardiovascular Associates Research, LLC | Covington, LA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Triglycerides
BAY 2433334
CER-001
TQJ230
Finerenone
Pemafibrate
Apixaban

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 7 total trials

Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD

Study CTQJ230A12303 is a randomized, double-blind placebo-controlled, Phase IIIb study to evaluate the efficacy, safety and tolerability of pelacarse...

Enrolling
Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease
Drug: TQJ230
Drug: Placebo

To demonstrate the safety and efficacy of the SurVeil Drug-Coated Balloon (DCB) for treatment of subjects with symptomatic peripheral artery disease...

Active, not recruiting
Peripheral Vascular Disease
Femoropopliteal Artery Occlusion
Device: Medtronic IN.PACT Admiral DCB
Device: Surmodics SurVeil DCB

Trial sponsors

Bayer logo
C
Kowa logo
Novartis logo
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems